Details of Protein
General Information of Protein (ID: PRT01697) | |||||
---|---|---|---|---|---|
Name | Transcriptional coactivator YAP1 (yap1) | ||||
Synonyms |
Click to Show/Hide Synonyms of This Protein
Transcriptional coactivator YAP1; zYAP; Protein yorkie homolog; Yes-associated protein YAP65 homolog;
|
||||
Gene Name | yap1 | Gene ID | |||
UniProt ID | |||||
Family | Transcriptional coactivator (TC) | ||||
Click to Show/Hide the Molecular/Functional Data (Sequence/Structure/Function) of This Protein | |||||
Sequence |
MDPNQHNPPAGHQIVHVRGDSETDLEALFNAVMNPKNTIVPPSVPMRLRKLPDSFFTPPE
PKSHSRQASTDAGTAGTVTPHHVRAHSSPASLQLGAVSPGALTSMGPANAPPQHLRQSSY EIPDDMPLPPGWEMAKTPSGQRYFLNHNDQTTTWQDPRKALLQMNQAAPASPVPVQQQNI MNPASGPLPDGWEQAITSEGEIYYINHKNKTTSWLDPRLDPRFAMNQQRISQSAPVKQGS QLPSSPQSGVMSGNNPIRLQQIHIEKERLRIKQELLRQRPQELALRNQLPTSMEQDGGTQ NPVSSPGMGQDARNMTTNSSDPFLNSGTYHSRDESTDSGLSMSSYSVPRTPDDFLNSVDE METGDTLGPGSMATQPSRFPDYLDAIPGTDVDLGTLEGESMAVEGEELMPSLQEALSSDI LNDMESVLAATKIDKENFLTWL |
||||
Function | Transcriptional regulator which can act both as a coactivator and a corepressor and is the critical downstream regulatory target in the Hippo signaling pathway that plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. Required for expansion of the neural plate and neural plate border zone progenitor pools. Acts as a direct regulator of pax3 expression via interaction with tead1. Plays a key role in tissue tension and 3D tissue shape by regulating cortical actomyosin network formation. | ||||
Regulatory Network | |||||
Full List of Metabolite(s) Regulated by This Protein | ||||||
---|---|---|---|---|---|---|
Nucleosides, nucleotides, and analogues | ||||||
Adenosine monophosphate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Decrease of Yap mRNA caused by Yap loss-of-function mutation | |||||
Induced Change | Adenosine monophosphate concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that decrease of Yap mRNA caused by Yap loss-of-function mutation leads to the increase of adenosine monophosphate levels compared with control group. | |||||
ATP | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Decrease of Yap mRNA caused by Yap loss-of-function mutation | |||||
Induced Change | ATP concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that decrease of Yap mRNA caused by Yap loss-of-function mutation leads to the decrease of ATP levels compared with control group. | |||||
Cytidine monophosphate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Decrease of Yap mRNA caused by Yap loss-of-function mutation | |||||
Induced Change | Cytidine monophosphate concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that decrease of Yap mRNA caused by Yap loss-of-function mutation leads to the increase of cytidine monophosphate levels compared with control group. | |||||
dATP | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Decrease of Yap mRNA caused by Yap loss-of-function mutation | |||||
Induced Change | dATP concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that decrease of Yap mRNA caused by Yap loss-of-function mutation leads to the decrease of dATP levels compared with control group. | |||||
dGTP | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Decrease of Yap mRNA caused by Yap loss-of-function mutation | |||||
Induced Change | dGTP concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that decrease of Yap mRNA caused by Yap loss-of-function mutation leads to the decrease of dGTP levels compared with control group. | |||||
Guanosine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Decrease of Yap mRNA caused by Yap loss-of-function mutation | |||||
Induced Change | Guanosine concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that decrease of Yap mRNA caused by Yap loss-of-function mutation leads to the decrease of guanosine levels compared with control group. | |||||
Guanosine monophosphate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Decrease of Yap mRNA caused by Yap loss-of-function mutation | |||||
Induced Change | Guanosine monophosphate concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that decrease of Yap mRNA caused by Yap loss-of-function mutation leads to the increase of guanosine monophosphate levels compared with control group. | |||||
Guanosine triphosphate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Decrease of Yap mRNA caused by Yap loss-of-function mutation | |||||
Induced Change | Guanosine triphosphate concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that decrease of Yap mRNA caused by Yap loss-of-function mutation leads to the decrease of guanosine triphosphate levels compared with control group. | |||||
Uridine 5'-monophosphate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Decrease of Yap mRNA caused by Yap loss-of-function mutation | |||||
Induced Change | Uridine 5'-monophosphate concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that decrease of Yap mRNA caused by Yap loss-of-function mutation leads to the increase of uridine 5'-monophosphate levels compared with control group. | |||||
Lipids and lipid-like molecules | ||||||
Fluorodeoxyglucose F18 | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Decrease of Yap mRNA caused by Yap loss-of-function mutation | |||||
Induced Change | Fluorodeoxyglucose F18 concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that decrease of Yap mRNA caused by Yap loss-of-function mutation leads to the increase of fluorodeoxyglucose f18 levels compared with control group. | |||||
Organic acids and derivatives | ||||||
Lactic acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Decrease of Yap mRNA caused by Yap loss-of-function mutation | |||||
Induced Change | Lactic acid concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that decrease of Yap mRNA caused by Yap loss-of-function mutation leads to the decrease of lactic acid levels compared with control group. | |||||
Ureidosuccinic acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Decrease of Yap mRNA caused by Yap loss-of-function mutation | |||||
Induced Change | Ureidosuccinic acid concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that decrease of Yap mRNA caused by Yap loss-of-function mutation leads to the decrease of ureidosuccinic acid levels compared with control group. | |||||
Organic oxygen compounds | ||||||
Beta-D-Fructose 6-phosphate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Decrease of Yap mRNA caused by Yap loss-of-function mutation | |||||
Induced Change | Beta-D-Fructose 6-phosphate concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that decrease of Yap mRNA caused by Yap loss-of-function mutation leads to the decrease of beta-D-Fructose 6-phosphate levels compared with control group. | |||||
Dihydroxyacetone phosphate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Decrease of Yap mRNA caused by Yap loss-of-function mutation | |||||
Induced Change | Dihydroxyacetone phosphate concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that decrease of Yap mRNA caused by Yap loss-of-function mutation leads to the decrease of dihydroxyacetone phosphate levels compared with control group. | |||||
Glucose 6-phosphate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Decrease of Yap mRNA caused by Yap loss-of-function mutation | |||||
Induced Change | Glucose 6-phosphate concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that decrease of Yap mRNA caused by Yap loss-of-function mutation leads to the decrease of glucose 6-phosphate levels compared with control group. | |||||
Glyceraldehyde 3-phosphate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Decrease of Yap mRNA caused by Yap loss-of-function mutation | |||||
Induced Change | Glyceraldehyde 3-phosphate concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that decrease of Yap mRNA caused by Yap loss-of-function mutation leads to the decrease of glyceraldehyde 3-phosphate levels compared with control group. | |||||
Organoheterocyclic compounds | ||||||
Cytosine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Decrease of Yap mRNA caused by Yap loss-of-function mutation | |||||
Induced Change | Cytosine concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that decrease of Yap mRNA caused by Yap loss-of-function mutation leads to the decrease of cytosine levels compared with control group. | |||||
References | |||||
---|---|---|---|---|---|
1 | Yap regulates glucose utilization and sustains nucleotide synthesis to enable organ growth. EMBO J. 2018 Nov 15;37(22):e100294. |
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.